Biosenta

Biosenta ROCE

The Return on Capital Employed (ROCE) of Biosenta (ZRO.CN) as of Oct 22, 2026 is 15.04 %. In the previous year, Return on Capital Employed (ROCE) was 18.41 % — a change of -18.30% (lower).

ROCE

15.04 %

YoY

-18.30%

Last updated:

In 2024, Biosenta's return on capital employed (ROCE) was 15.04 %, a -18.30% increase from the 18.41 % ROCE in the previous year.

The Biosenta ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2017
-147.78 CAD
Jan 1, 2018
29.23 CAD
Jan 1, 2019
35.76 CAD
Jan 1, 2020
39.00 CAD
Jan 1, 2021
77.86 CAD
Jan 1, 2022
40.92 CAD
Jan 1, 2023
18.41 CAD
Jan 1, 2024
15.04 CAD
The Biosenta ROCE history
YEARROCEYoY
15.04 %-18.30%
18.41 %-55.00%
40.92 %-47.45%
77.86 %+99.63%
39.00 %+9.08%
35.76 %+22.33%
29.23 %-119.78%
-147.78 %+133.36%
-63.33 %-171.66%
88.37 %-123.88%
-370.05 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Biosenta Stock analysis

What does Biosenta do? Biosenta Inc develops and manufactures chemical compounds using encapsulated nanotechnology for household and industrial applications. The company offers true Disinfectant, recognized by Health Canada for combating COVID-19, and Tri-Filler, which uses nano-technology particles to provide anti-microbial protection against bacteria, fungi, and viruses. True Disinfectant targets superbug pathogens while ensuring safety for humans and the environment. Tri-Filler is embedded in materials like drywall, plastic, resin, and textiles to prevent microbial growth and protect surfaces from mold and bacteria. The company's products are designed for both household and industrial use, with a focus on safety and long-term protection. Biosenta Inc's primary customers are households and industrial clients seeking effective disinfection and anti-microbial solutions. The true Disinfectant is marketed for its Health Canada recognition in the fight against COVID-19, appealing to consumers and businesses needing reliable pathogen control. Tri-Filler targets industries requiring material protection, such as construction and manufacturing, where drywall, plastic, and resin products are common. These segments value the company's technology for its dual benefits of safety and durability. The company generates revenue through the sale of its chemical compounds, specifically the true Disinfectant and Tri-Filler products. These products are sold to end-users in household and industrial markets, with a focus on applications requiring microbial protection. The business model relies on the unique nanotechnology embedded in its products, which provides long-lasting anti-microbial effects without compromising safety. Biosenta Inc's offerings cater to growing demand for safe and effective solutions in disinfection and material protection. Biosenta is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Biosenta's Return on Capital Employed (ROCE)

Biosenta's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Biosenta's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Biosenta's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Biosenta’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Biosenta stock

Return on Capital Employed (ROCE) of Biosenta is 15.04 % in 2024.

Return on Capital Employed (ROCE) of Biosenta changed from 18.41 % to 15.04 %, representing a -18.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Biosenta since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Biosenta with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Biosenta

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Biosenta